SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-11-012602
Filing Date
2011-03-07
Accepted
2011-03-07 08:00:49
Documents
5
Period of Report
2011-03-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a11-7362_18k.htm 8-K 25474
2 EX-99.1 a11-7362_1ex99d1.htm EX-99.1 289881
3 GRAPHIC g73621mni001.jpg GRAPHIC 2323
4 GRAPHIC g73621mni002.jpg GRAPHIC 2324
5 GRAPHIC g73621mli001.gif GRAPHIC 2671
  Complete submission text file 0001104659-11-012602.txt   327005
Mailing Address 7015 ALBERT EINSTEIN DRIVE COLUMBIA MD 21046
Business Address 7015 ALBERT EINSTEIN DRIVE COLUMBIA MD 21046 443-545-1819
OSIRIS THERAPEUTICS, INC. (Filer) CIK: 0001360886 (see all company filings)

IRS No.: 710881115 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32966 | Film No.: 11666675
SIC: 2836 Biological Products, (No Diagnostic Substances)